Armira Partners has invested in Virtamed, one of the world's leading developers of virtual medical reality simulators specializing in minimally invasive surgery and endoscopy.
Virtamed revolutionizes surgical training with high-fidelity mixed reality simulators that digitally recreate surgeries with submillimeter precision. This technology enables the simulation of surgical procedures under highly realistic conditions, preparing medical trainees for the complex challenges of the operating room. Virtamed’s simulation products offer training scenarios that increase in complexity and are based on curricula recommended by medical societies, designed to help trainees acquire specific skills.
These simulators provide significant advantages for surgical training. They create a realistic training environment where trainee surgeons can develop their skills without risking patient safety. They also reduce the costs associated with disposable materials typically used in training. Moreover, the efficient design of curricula can significantly shorten the time required to acquire essential surgical skills.
Based in Schlieren, Zurich, Virtamed employs over 120 people and is a leader in this specialized field. By enhancing training programs for surgeons and medical training institutions, Virtamed contributes significantly to the advancement of medical education and patient safety.
Armira Partners is a leading investment holding company specializing in direct investments in mid-market, profitable family businesses, and ambitious growth companies. It provides entrepreneurial capital for long-term partnerships and aims to be the preferred investment partner for family investors and entrepreneurs in mid-market and resilient growth businesses.
Armira invests between 20 and 200 million euros in majority stakes in mid-sized, growing "hidden champions" and between 10 and 100 million euros in growth capital in European technology companies with fast-growing, proven business models. Armira focuses on established, profitable companies with sustainable business models in the DACH region, Northern Italy, and beyond.
Armira's corporate culture is characterized by values such as excellence, integrity, respect, humility, and passion. These values support the company in fulfilling its social responsibility, making long-term sustainable decisions, and strengthening the trust of investors and partner companies.
For more detailed information on Armira Partners and its investment strategies, please visit Armira's homepage.
Founded in 2011 and based in Munich, ConAlliance offers a comprehensive range of services, including mergers and acquisitions, due diligence, corporate finance, and healthcare research. Specific services include divestitures, acquisitions, buy-outs and buy-ins, distressed takeovers, acquisition and growth financing, debt advisory, real estate appraisals, and valuation analysis. ConAlliance specializes exclusively in the healthcare industry, providing tailored advisory services in this sector.
ConAlliance acted as the commercial advisor to Armira Partners for this transaction.
The ConAlliance team for this transaction was led by Dipl.-Kfm. Günter Carl Hober, Managing Partner, supported by Dipl.-Kfm. Martin E. Franz, Partner, and a team from ConAlliance London led by Cliff Murphy, Managing Director (ConAlliance UK Ltd.).
For more information, please visit www.conalliance.com.